Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.

Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadié M, Monnereau A, Osca-Gelis G, Visser O, De Angelis R; the EUROCARE-5 Working Group.

Lancet Oncol. 2014 Jul 11. pii: S1470-2045(14)70282-7. doi: 10.1016/S1470-2045(14)70282-7. [Epub ahead of print]

PMID:
25030467
[PubMed - as supplied by publisher]
2.

Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health?

Schöttker B, Saum KU, Perna L, Ordóñez-Mena JM, Holleczek B, Brenner H.

Eur J Epidemiol. 2014 Mar;29(3):199-210. doi: 10.1007/s10654-014-9894-3. Epub 2014 Mar 29.

PMID:
24682834
[PubMed - indexed for MEDLINE]
3.

Survival of cancer patients in urban and rural areas of Germany--a comparison.

Nennecke A, Geiss K, Hentschel S, Vettorazzi E, Jansen L, Eberle A, Holleczek B, Gondos A, Brenner H; GEKID cancer survival working group.

Cancer Epidemiol. 2014 Jun;38(3):259-65. doi: 10.1016/j.canep.2014.02.011. Epub 2014 Mar 27.

PMID:
24680643
[PubMed - in process]
4.

Frailty prevalence and 10-year survival in community-dwelling older adults: results from the ESTHER cohort study.

Saum KU, Dieffenbach AK, Müller H, Holleczek B, Hauer K, Brenner H.

Eur J Epidemiol. 2014 Mar;29(3):171-9. doi: 10.1007/s10654-014-9891-6. Epub 2014 Mar 27.

PMID:
24671603
[PubMed - indexed for MEDLINE]
5.

F2RL3 methylation in blood DNA is a strong predictor of mortality.

Zhang Y, Yang R, Burwinkel B, Breitling LP, Holleczek B, Schöttker B, Brenner H.

Int J Epidemiol. 2014 Feb 7. [Epub ahead of print]

PMID:
24510982
[PubMed - as supplied by publisher]
6.

Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century.

Pulte D, Barnes B, Jansen L, Eisemann N, Emrich K, Gondos A, Hentschel S, Holleczek B, Kraywinkel K, Brenner H; GEKID Cancer Survival Working Group.

J Hematol Oncol. 2013 Sep 16;6(1):70. doi: 10.1186/1756-8722-6-70.

PMID:
24499592
[PubMed - in process]
Free PMC Article
7.

Survival of adults with acute lymphoblastic leukemia in Germany and the United States.

Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, Holleczek B, Eberle A, Brenner H; GEKID Cancer Survival Working Group.

PLoS One. 2014 Jan 27;9(1):e85554. doi: 10.1371/journal.pone.0085554. eCollection 2014.

PMID:
24475044
[PubMed - in process]
Free PMC Article
8.

Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century.

Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H; GEKID Cancer Survival Working Group.

Br J Haematol. 2014 Mar;164(6):851-7. doi: 10.1111/bjh.12722. Epub 2014 Jan 16.

PMID:
24433418
[PubMed - indexed for MEDLINE]
9.

A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.

Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Jansen L, Brenner H; GEKID Cancer Survival Working Group.

Cancer Med. 2013 Oct;2(5):718-24. doi: 10.1002/cam4.116. Epub 2013 Aug 27.

PMID:
24403237
[PubMed - in process]
Free PMC Article
10.

[Rising incidence of papillary thyroid carcinoma in Germany].

Radespiel-Tröger M, Batzler WU, Holleczek B, Luttmann S, Pritzkuleit R, Stabenow R, Urbschat I, Zeissig SR, Meyer M; Im Namen der Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jan;57(1):84-92. doi: 10.1007/s00103-013-1884-1. German.

PMID:
24357177
[PubMed - in process]
11.

Adherence to physician recommendations for surveillance in opportunistic colorectal cancer screening: the necessity of organized surveillance.

Stock C, Holleczek B, Hoffmeister M, Stolz T, Stegmaier C, Brenner H.

PLoS One. 2013 Dec 6;8(12):e82676. doi: 10.1371/journal.pone.0082676. eCollection 2013.

PMID:
24324821
[PubMed - in process]
Free PMC Article
12.

Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the Cancer Survivorship--a multi-regional population-based study.

Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.

Psychooncology. 2014 May;23(5):547-54. doi: 10.1002/pon.3452. Epub 2013 Nov 30.

PMID:
24293081
[PubMed - in process]
13.

Cancer incidence in ethnic German migrants from the Former Soviet Union in comparison to the host population.

Winkler V, Holleczek B, Stegmaier C, Becher H.

Cancer Epidemiol. 2014 Feb;38(1):22-7. doi: 10.1016/j.canep.2013.10.011. Epub 2013 Nov 23.

PMID:
24275258
[PubMed - in process]
14.

Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany.

Jansen L, Eberle A, Emrich K, Gondos A, Holleczek B, Kajüter H, Maier W, Nennecke A, Pritzkuleit R, Brenner H; GEKID Cancer Survival Working Group.

Int J Cancer. 2014 Jun 15;134(12):2951-60. doi: 10.1002/ijc.28624. Epub 2013 Dec 2.

PMID:
24259308
[PubMed - indexed for MEDLINE]
15.

Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements.

Perna L, Schöttker B, Holleczek B, Brenner H.

J Clin Endocrinol Metab. 2013 Dec;98(12):4908-15. doi: 10.1210/jc.2013-2424. Epub 2013 Oct 8.

PMID:
24106288
[PubMed - indexed for MEDLINE]
16.

Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality.

Perna L, Hoffmeister M, Schöttker B, Arndt V, Haug U, Holleczek B, Burwinkel B, Ordóñez-Mena JM, Brenner H.

Cancer Epidemiol. 2013 Dec;37(6):905-7. doi: 10.1016/j.canep.2013.09.007. Epub 2013 Sep 27.

PMID:
24075799
[PubMed - in process]
17.

High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality.

Silbernagel G, Schöttker B, Appelbaum S, Scharnagl H, Kleber ME, Grammer TB, Ritsch A, Mons U, Holleczek B, Goliasch G, Niessner A, Boehm BO, Schnabel RB, Brenner H, Blankenberg S, Landmesser U, März W.

Eur Heart J. 2013 Dec;34(46):3563-71. doi: 10.1093/eurheartj/eht343. Epub 2013 Sep 7.

PMID:
24014391
[PubMed - in process]
18.

Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.

Arnold M, Holterhues C, Hollestein LM, Coebergh JW, Nijsten T, Pukkala E, Holleczek B, Tryggvadóttir L, Comber H, Bento MJ, Diba CS, Micallef R, Primic-Žakelj M, Izarzugaza MI, Perucha J, Marcos-Gragera R, Galceran J, Ardanaz E, Schaffar R, Pring A, de Vries E.

J Eur Acad Dermatol Venereol. 2013 Aug 21. doi: 10.1111/jdv.12236. [Epub ahead of print]

PMID:
23962170
[PubMed - as supplied by publisher]
19.

Breast cancer survival in Germany: a population-based high resolution study from Saarland.

Holleczek B, Jansen L, Brenner H.

PLoS One. 2013 Jul 31;8(7):e70680. doi: 10.1371/journal.pone.0070680. Print 2013.

PMID:
23936237
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany.

Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H; GEKID Cancer Survival Working Group.

PLoS One. 2013 Jul 5;8(7):e68077. doi: 10.1371/journal.pone.0068077. Print 2013.

PMID:
23861851
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk